UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM10-Q

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 20202021

 

OR

 

TRANSACTION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _______ to _______

 

COMMISSION FILE NO. 0-17629

 

ADM TRONICS UNLIMITED, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

(State or Other Jurisdiction

of Incorporation or organization)

22-1896032

(I.R.S. Employer

Identification Number)

 

224-S Pegasus Ave., Northvale, New Jersey 07647

(Address of Principal Executive Offices)

 

Registrant's Telephone Number, including area code: (201) 767-6040

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

None

N/A

N/A

 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days:  YESYes ☒ NONo ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

YESYes ☒ NONo

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐

Accelerated filer  ☐

Non-accelerated filer ☐

Smaller reporting company ☒

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

YESYes ☐ NONo

 

State the number of shares outstanding of each of the Issuer's classes of common equity, as of the latest practicable date:

 

67,588,504 shares of Common Stock, $.0005 par value, as of November 16, 2020.22, 2021

 

 

 

 

ADM TRONICS UNLIMITED, INC. AND SUBSIDIARY

 

INDEX

 

Page

Number

Part I - Financial Information

Item 1.

Condensed Consolidated Financial Statements:

Condensed Consolidated Balance Sheets – September 30, 20202021 (unaudited) and March 31, 20202021 (audited)

3

Condensed Consolidated Statements of Operations for the three and six months ended September 30, 20202021 and 20192020 (unaudited)

4

Condensed Consolidated Statement of Stockholders’ Equity for the six months ended September 30, 20202021 (unaudited)

5

Condensed Consolidated Statements of Cash Flows for the six months ended September 30, 20202021 and 20192020 (unaudited)

6

Notes to Condensed Consolidated Financial Statements (unaudited)

7

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

16

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

19

Item 4.

Controls and Procedures

19

Part II - Other Information

Item 1.

Legal Proceedings

1920

Item 1A.

Risk Factors

1920

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

20

Item 3.

Defaults Upon Senior Securities

20

Item 4.

Mine Safety Disclosures

20

Item 5.

Other Information

20

Item 6.

Exhibits

2021

 

 

 

PART I. FINANCIAL INFORMATION

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

ADM TRONICS UNLIMITED, INC. AND SUBSIDIARY

CONDENSED CONSOLIDATED BALANCE SHEETS 

 

 

September 30,

  

March 31,

  

September 30,

 

March 31,

 
 

2020

  

2020

  

2021

 

2021

 
 (Unaudited)  

(Audited)

  

(Unaudited)

  

(Audited)

 

ASSETS

            
         

Current assets:

         

Cash and cash equivalents

 $1,459,211  $1,438,714  $1,264,488  $1,546,950 

Accounts receivable, net of allowance for doubtful accounts of $225,000 at September 30, 2020 and March 31, 2020, respectively

  1,018,618   860,539 

Accounts receivable, net of allowance for doubtful accounts of $250,000 and $50,000 at September 30, 2021 and March 31, 2020, respectively

 1,024,710  1,153,684 

Inventories

  454,317   372,635  296,288  227,234 

Prepaid expenses and other current assets

  43,761   23,525   60,993   47,039 
         

Total current assets

  2,975,907   2,695,413   2,646,479   2,974,907 
         

Other Assets:

         

Property and equipment, net of accumulated depreciation of $164,353 and $145,602 at September 30, 2020 and March 31, 2020, respectively

  39,207   57,958 

Operating lease asset

  672,688   706,307 

Accounts receivable-related party

  330,090   330,090 

Property and equipment, net of accumulated depreciation of $196,820 and $181,289 at September 30, 2021 and March 31, 2021, respectively

 6,740  22,271 

Operating lease right-of-use asset, net of accumulated depreciation of $266,832 and $225,781 at September 30, 2021 and March 31, 2021, respectively

 554,188  595,240 

Accounts receivable - long-term portion

 116,913  139,496 

Accounts receivable-related party, net of allowance for doubtful accounts of $250,000 at September 30, 2021 and March 31, 2021, respectively

 80,090  80,090 

Inventories - long-term portion

  132,080   132,080  211,634  211,634 

Intangible assets, net of accumulated amortization of $15,430 and $14,091 at September 30, 2020 and March 31, 2020, respectively

  20,364   21,703 

Intangible assets, net of accumulated amortization of $18,311 and $16,871 at September 30, 2021 and March 31, 2021, respectively

 17,483  18,923 

Other assets

  90,538   90,538  90,538  90,538 

Deferred tax asset

  1,008,000   1,019,000   1,231,000   1,081,000 

Total other assets

  2,292,967   2,357,676   2,308,586   2,239,192 
         

Total assets

 $5,268,874  $5,053,089  $4,955,065  $5,214,099 
         

LIABILITIES AND STOCKHOLDERS' EQUITY

            
         

Current liabilities:

         

PPP loan - current

 $127,000  $- 

Financing lease payable

  5,365   21,458 

PPP loans

 $190,227  $288,257 

Line of credit

  55,000   30,000  253,742  226,413 

Warrant liability

 287,844  0 

Operating lease liability-current

  69,827   68,106  73,399  71,591 

Accounts payable

  367,281   365,475  313,363  364,305 

Accrued expenses and other current liabilities

  152,540   136,188  129,328  130,384 

Customer deposits

  375,847   354,745  246,232  293,638 

Due to stockholder

  71,277   100,017   79,040   89,391 

Total current liabilities

  1,224,137   1,075,989   1,573,175   1,463,979 
         

Long-term liabilities

         

Operating lease liability - noncurrent

  602,861   638,201 
PPP loan - noncurrent  254,000   - 

PPP loan, net of current liabilities

 162,040  425,285 

Operating lease liability

  529,452   566,609 

Total long-term liabilities

  856,861   638,201   691,492   991,894 
         
         

Total liabilities

 $2,080,998  $1,714,190  $2,264,667  $2,455,873 
         

Stockholders' equity:

         

Preferred stock, $.01 par value; 5,000,000 shares authorized, no shares issued and outstanding

 $-  $- 

Common stock, $0.0005 par value; 150,000,000 shares authorized, 67,588,504 shares issued and outstanding

  33,794   33,794 

Preferred stock, $.01 par value; 5,000,000 shares authorized, no shares issued and outstanding

 $0  $0 

Common stock, $0.0005 par value; 150,000,000 shares authorized, 67,588,504 shares issued and outstanding

 33,794  33,794 

Additional paid-in capital

  33,302,871   33,294,069  33,311,672  33,311,672 

Accumulated deficit

  (30,148,789)  (29,988,964)  (30,655,068)  (30,587,240)

Total stockholders' equity

  3,187,876   3,338,899   2,690,398   2,758,226 
         

Total liabilities and stockholders' equity

 $5,268,874  $5,053,089  $4,955,065  $5,214,099 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

3

 

ADM TRONICS UNLIMITED, INC. AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENTS OFOPERATIONS

FOR THETHREE AND SIXMONTHS ENDEDSEPTEMBER 30, 2020 2021AND 20192020

(Unaudited) 

 

 

Three months ended

  

Six months ended

  

Three months ended

 

Six months ended

 
 

September 30,

  

September 30,

  

September 30,

 

September 30,

 
 

2020

  

2019

  

2020

  

2019

  

2021

 

2020(reclassified)

 

2021

 

2020(reclassified)

 
                 

Net revenues

 $927,085  $956,791  $1,496,178  $1,787,612  $851,859  $927,085  $1,573,217  $1,496,178 
                 

Cost of sales

  578,546   544,448   980,049   940,457   489,195  561,628   908,571  946,421 
                 

Gross Profit

  348,539   412,343   516,129   847,155   362,664  365,457   664,646  549,757 
                 

Operating expenses:

                 

Research and development

  126,506   148,751   252,410   294,517  132,773  126,506  294,141  252,410 

Selling, general and administrative

  209,302   301,835   429,082   516,090  472,133  209,302  633,465  429,082 

Stock based compensation

  8,802   -   8,802   -  0  8,802  0  8,802 

Consulting

 287,844  0  287,844  0 

Depreciation and amortization

  (1,437)  5,505   4,339   11,011  22,488  15,481  44,767  37,967 
                     

Total operating expenses

  343,173   456,091   694,633   821,618   915,238  360,091   1,260,217  728,261 
                 

Income (loss) from operations

  5,366   (43,748)  (178,504)  25,537   (552,574) 5,366   (595,571) (178,504)
                 

Other income (expense):

                 

EIDL Grant

  -   -   10,000   -  0  0  0  10,000 

Forgiveness of Payroll Protection Program loan

 361,275  0  361,275  0 

Interest income

  4,807   6,541   9,716   13,694  755  4,807  1,819  9,716 

Interest expense

  (1,262)  (1,202)  (2,537)  (2,871)

Total other income (expense)

  3,545   5,339   17,179   10,823 

Interest and finance expenses

  (2,930) (1,262)  (5,169) (2,537)

Total other income

  359,100  3,545   357,925  17,179 
                 

Income (loss) before provision for income taxes

  8,911   (38,409)  (161,325)  36,360   (193,474) 8,911   (237,646) (161,325)
                 

Provision for (benefit) income taxes:

                

Provision (benefit) for income taxes:

 

Current

  -   -   (12,500)  1,000  (25,318) 0  (19,818) (12,500)

Deferred

  (53,000)  (11,000)  11,000   10,000   (131,000) (53,000)  (150,000) 11,000 

Total provision (benefit) for income taxes

  (53,000)  (11,000)  (1,500)  11,000 

Total (benefit) for income taxes

  (156,318) (53,000)  (169,818) (1,500)
                 

Net income (loss)

 $61,911  $(27,409) $(159,825) $25,360  $(37,156) $61,911  $(67,828) $(159,825)
                 

Basic and diluted per common share:

 $0.00  $(0.00) $(0.00) $0.00  $(0.00) $(0.00) $(0.00) $(0.00)
                 

Weighted average shares of common stock outstanding - basic and diluted

  67,588,504   67,588,504   67,588,504   67,588,504   67,588,504  67,588,504   67,588,504  67,588,504 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

4

 

ADMTRONICS UNLIMITED, INC. AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDER’S STOCKHOLDERS’ EQUITY

FOR THESIXMONTHS ENDEDSEPTEMBER 30, 2020 2021

(Unaudited)

 

  

Common

Stock

  

Common

Stock

  

Additional Paid-in

  

Accumulated

     
  

Shares

  

Amount

  

Capital

  

Deficit

  

Total

 
                     
                     

Balance at March 31, 2020

  67,588,504  $33,794  $33,294,069  $(29,988,964) $3,338,899 
                     

Net loss

  -   -   -   (159,825)  (159,825)
                     

Stock based compensation

  -   -   8,802   -   8,802 
                     

Balance at September 30, 2020

  67,588,504  $33,794  $33,302,871  $(30,148,789) $3,187,876 
  

Common
Stock

  

Common
Stock

  

Additional
Paid-in

  

Accumulated

     
  

Shares

  

Amount

  

Capital

  

Deficit

  

Total

 
                     
                     

Balance at March 31, 2021

  67,588,504  $33,794  $33,311,672  $(30,587,240) $2,758,226 
                     

Net (loss)

  -   -   -   (67,828)  (67,828)
                     

Balance at September 30, 2021

  67,588,504  $33,794  $33,311,672   (30,655,068)  2,690,398 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

5

 

ADMTRONICS UNLIMITED, INC. AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THESIXMONTHS ENDEDSEPTEMBER 30, 2020 2021AND 20192020

(Unaudited) 

 

 

2020

  

2019

  

2021

  

2020 (reclassified)

 

Cash flows from operating activities:

         

Net income (loss)

 $(159,825) $25,360 

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

        

Net (loss)

 $(67,828) $(159,825

)

Adjustments to reconcile net (loss) to net cash (used in) operating activities:

 

Depreciation and amortization

  20,090   19,449  58,023  53,719 

Write-off of inventories

  19,888   46,715  21,979  19,888 

Stock based compensation

  8,802     
Stock Based Compensation 0  8,802 

Deferred taxes

  11,000   10,000  (150,000) 11,000 

Non-cash operating lease expense

  33,619   31,992 

Non-cash interest expense

  17,309   18,946  15,589  17,309 

Forgiveness of Paycheck Protection Program loan

 (361,275) 0 
Bad debt write off 200,000  0 
Warrant liability 287,844  0 

Changes in operating assets and liabilities balances:

         

Accounts receivable

  (158,079)  (90,863) (48,443

)

 (158,079)

Inventories

  (101,570)  (93,081) (91,033

)

 (101,570

)

Prepaid expenses and other current assets

  (20,236)  (86,643) (13,954

)

 (20,236

)

Accounts payable

  1,806   61,244  (50,942

)

 1,806

 

Customer deposits

  21,102   350,087  (47,406

)

 21,102 

Accrued expenses and other current liabilities

  16,352   8,332  (1,056

)

 16,352

 

Due to shareholder

  (28,740)  6,895 

Payments of operating lease liability

  (50,928)  (50,938)  (50,938

)

  (50,938

)

Net cash provided by (used in) operating activities

  (369,410)  257,495 

Net cash (used in) operating activities

  (299,440

)

  (340,670

)

         
         

Cash flows provided (used) in financing activities:

         

Due to stockholder

 (10,351) (28,740

)

Proceeds from line of credit

  25,000   115,000  132,000  25,000 

Repayments of line of credit

  -   (284,885) (104,671) 0 

Proceeds from PPP loan

  381,000   - 

Proceeds from PPP Loan

 0  381,000 

Repayments on financing lease payable

  (16,093)  (16,094)  0   (16,093

)

         

Net cash provided by (used in) financing activities

  389,907   (185,979)  16,978   361,167 
         

Net increase in cash and cash equivalents

  20,497   71,516 

Net (decrease) increase in cash and cash equivalents

 (282,462

)

 20,497 
         

Cash and cash equivalents - beginning of period

  1,438,714   1,555,687   1,546,950   1,438,714 
         

Cash and cash equivalents - end of period

 $1,459,211  $1,627,203  $1,264,488  $1,459,211 
         
         

Cash paid for:

         

Interest

 $2,537  $2,871  $4,840  $2,537 
        

Non-cash operating activities:

        

Operating lease right-of-use asset and liability recorded upon adoption of ASC 842

 $-  $771,098 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

6

 

ADM TRONICS UNLIMITED, INC. AND SUBSIDIARY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

For the Three and Six Months Ended SEPTEMBER 30, 20202021

 

 

 

NOTE1- NATURE OF BUSINESS

 

ADM Tronics Unlimited, Inc. ("we", "us", "the“the Company" or "ADM"), was incorporated under the laws of the state of Delaware on  November 24, 1969. We are a manufacturing and engineering concern whose principal lines of business are the design, manufacture and sale of electronics of our own products or on a contract manufacturing basis; the production and sale of chemical and antistatic products; and, research, development and engineering services.

 

Electronic equipment is manufactured in accordance with customer specifications on a contract basis. Our electronic device product line consists principally of proprietary devices used in diagnostics and therapeutics of humans and animals and electronic controllers for spas and hot tubs. These products are sold to customers located principally in the United States. We are registered with the FDA as a contract manufacturing facility and we manufacture medical devices for customers in accordance with their designs and specifications. Our chemical product line is principally comprised of water-based chemical products used in the food packaging and converting industries, and anti-static conductive paints, coatings and other products. These products are sold to customers located in the United States, Australia, Asia and Europe. We also provide research, development, regulatory and engineering services to customers. Our Sonotron Medical Systems, Inc. subsidiary (“Sonotron”) is involved in medical electronic therapeutic technology.

 

The accompanying unaudited condensed consolidated financial statements have been prepared by ADM pursuant to accounting principles generally accepted in the United States of America (“US GAAP”) and the rules and regulations of the Securities and Exchange Commission (“SEC”) including Form 10-Q10-Q and Regulation S-X.S-X. The information furnished herein reflects all adjustments (consisting of normal recurring accruals and adjustments) which are, in the opinion of management, necessary to fairly present the condensed financial position and operating results for the respective periods. Certain information and footnote disclosures normally present in annual financial statements prepared in accordance with US GAAP have been omitted pursuant to such rules and regulations. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and explanatory notes for the year ended March 31, 2020 2021 as disclosed in our annual report on Form 10-K10-K for that year. The operating results and cash flows for the three and six months ended September 30, 2020 (unaudited)2021 (unaudited) are not necessarily indicative of the results to be expected for the pending full year ending March 31, 2021.  2022.

 

 

NOTE2- SIGNIFICANT ACCOUNTING POLICIES

 

PRINCIPLES OF CONSOLIDATION

 

The condensed consolidated financial statements include the accounts of ADM Tronics Unlimited, Inc. and its wholly owned subsidiary, Sonotron Medical Systems, Inc.(the “Company”). All significant intercompany balances and transactions have been eliminated in consolidation.

USE OF ESTIMATES

 

These unaudited condensed consolidated financial statements have been prepared in accordance with US GAAP and, accordingly, requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. Significant estimates made by management include expected economic life and value of our deferred tax assets and related valuation allowance, write down of inventory, impairment of long-lived assets, allowance for doubtful accounts, and warranty reserves. Actual results could differ from those estimates.

FAIR VALUE OF FINANCIAL INSTRUMENTS

 

For certain of our financial instruments, including accounts receivable, accounts payable, and accrued expenses, the carrying amounts approximate fair value due to their relatively short maturities.

7

CASH AND CASH EQUIVALENTS

 

Cash equivalents are comprised of  highly liquid investments with original maturities of three months or less when purchased. We maintain our cash in bank deposit accounts, which at times,  may exceed federally insured limits. We have not experienced any losses to date as a result of this policy. Cash and cash equivalents held in these accounts are currently insured by the Federal Deposit Insurance Corporation (“FDIC”) up to a maximum of $250,000.$250,000. At September 30, 2020, 2021, approximately $1,305,000$1,051,000 exceeded the FDIC limit.

ACCOUNTS RECEIVABLE AND ALLOWANCE FOR DOUBTFUL ACCOUNTS

 

Accounts receivable are stated at the amount management expects to collect from outstanding balances. The carrying amounts of accounts receivable is reduced by a valuation allowance that reflects management's best estimate of the amounts that will not be collected. Management individually reviews all accounts receivable balances that exceed the due date and estimates the portion, if any, of the balance that will not be collected. Management provides for probable uncollectible amounts through a charge to expenses and a credit to a valuation allowance, based on its assessment of the current status of individual accounts. Balances that are still outstanding after management has used reasonable collection efforts are written off through a charge to the valuation allowance and a credit to accounts receivable. 

 

REVENUE RECOGNITION 

 

ELECTRONICS: 

 

We recognize revenue from the sale of our electronic products when they are shipped to the purchaser. We offer a limited 90-day warranty on our electronics products and contract manufacturing, and a limited 5-year warranty on our electronic controllers for spas and hot tubs. Historically, the amount of warranty revenue included in sales of our electronic products have been de minimus. We have no other post shipment obligations. For contract manufacturing, revenues are recognized after shipments of the completed products.

 

Amounts received from customers in advance of our satisfaction of applicable performance obligations are recorded as customer deposits. Such amounts are recognized as revenues when the related performance obligations are satisfied. Customer deposits of approximately $190,000$115,000 as of March 31, 2020 2021 were recognized as revenues during the six months ended September 30, 2020.2021.

 

CHEMICAL PRODUCTS:

 

Revenues are recognized when products are shipped to end users. Shipments to distributors are recognized as revenue when no right of return exists.

 

ENGINEERING SERVICES: 

 

We provide certain engineering services, including research, development, quality control, and quality assurance services along with regulatory compliance services. We recognize revenue from engineering services on a monthly basis over time as the applicable performance obligations are satisfied.  

 

All revenue is recognized net of discounts.

WARRANTY LIABILITIES

 

The Company’s provision for estimated future warranty costs is based upon historical relationship of warranty claims to sales. Based upon historical experience, the Company has concluded that no warranty liability is required as of the condensed consolidated balance sheet dates. However, the Company periodically reviews the adequacy of its product warranties and will record an accrued warranty reserve if necessary. Based on prior experience, no amounts have been accrued for potential warranty costs and actual costs were less than $2,000, for the three and six months ended September 30, 2020 2021 and 2019.2020.

 

INVENTORIES

 

Inventories are stated at the lower of cost (first-in, first-out(first-in, first-out method) and net realizable value. Inventories that are expected to be sold within one operating cycle (1(1 year) are classified as a current asset. Inventories that are not expected to be sold within 1 year, based on historical trends, are classified as Inventories - long term portion. Obsolete inventory is written off annually based on prior and expected future usage.

PROPERTY AND EQUIPMENT

 

We record our property and equipment at historical cost. We expense maintenance and repairs as incurred. Depreciation is provided for by the straight-line method over five to seven years, the estimated useful lives of the property and equipment.

 

8

INTANGIBLE ASSETS 

 

Intangible assets are reviewed for impairment annually whenever changes in circumstances indicate that the carrying amount  may not be recoverable. In reviewing for impairment, the Company compares the carrying value of the relevant asset to the estimated undiscounted future cash flows expected from the use of the assets and their eventual disposition. When the estimated undiscounted future cash flows are less than their carrying amount, an impairment loss is recognized equal to the difference between the assets’ fair value and its carrying value. 

ADVERTISING COSTS 

 

Advertising costs are expensed as incurred and amounted to $7,003 and $14,788, and $13,064 and $19,700 and $10,713 and $23,172 for the three and six months ended September 30, 2020 2021 and 2019,2020, respectively.

INCOME TAXES

 

We report the results of our operations as part of a consolidated Federal tax return with our subsidiary. Deferred income taxes result primarily from temporary differences between financial and tax reporting. Deferred tax assets and liabilities are determined based on the difference between the financial statement basis and tax basis of assets and liabilities using enacted tax rates. A valuation allowance is recorded to reduce a deferred tax asset to that portion that is expected to more likely than not be realized.

 

The Company has adopted the authoritative accounting guidance with respect to accounting for uncertainty in income taxes, which clarified the accounting and disclosures for uncertain tax positions related to income taxes recognized in the consolidated financial statements and addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the consolidated financial statements. The Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-notmore-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.

 

The Company files income tax returns in several jurisdictions. The Company’s tax returns remain subject to examination, by major jurisdiction, for the years ended March 31, as follows:

 

Jurisdiction

 

Fiscal Year

 

Federal

  2015

2016 and beyond

 

New Jersey

  2014

2015 and beyond

 

There are currently no tax years under examination by any major tax jurisdictions.

 

The Company will recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. As of September 30, 2020, 2021, and 2019,2020, the Company has no0 accrued interest or penalties related to uncertain tax positions.

NET EARNINGS PER SHARE

 

We compute basic earnings per share by dividing net income/loss by the weighted average number of common shares outstanding. Diluted earnings per share is computed similar to basic earnings per share, except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential shares had been issued and if the additional shares were dilutive. Common equivalent shares are excluded from the computation of net earnings per share if their effect is anti-dilutive. 

 

Per share basic and diluted earnings(loss) amounted to $0.00 and $(0.00) and $(0.00) and $0.00 for the three and six months ended September 30, 2021, and $0.00 and $(0.00) for the three and six months ended September 30, 2020, and September 30, 2019, respectively.respectively

 

LEASES

 

In February 2016, the Financial Accounting Standards Board (“FASB”) issued authoritative guidance which changeschanged financial reporting as it relates to leasing transactions. Under the new guidance, lessees are required to recognize a lease liability, measured on a discounted basis; and a right-of-use asset, for the lease term. The Company adopted this guidance as of April 1, 2019, using the modified retrospective approach which allowed it to initially apply the guidance as of the adoption date. The Company elected the package of practical expedients available under the new standard, which allowed the Company to forgo a reassessment of (1)(1) whether any expired or existing contracts are or contain leases, (2)(2) the lease classification for any expired or existing leases, and (3)(3) the initial direct costs for any existing leases.

 

9

The Company made a policy election to recognize short-term lease payments as an expense on a straight-line basis over the lease term. The Company defines a short-term lease as a lease that, at the commencement date, has a lease term of twelve months or less and does not contain an option to purchase the underlying asset that the leaseelease is reasonably certain to exercise. Related variable lease payments are recognized in the period in which the obligation is incurred.

 

The Company's lease agreement contains related non-lease components (e.g. taxes, etc.). The Company separates lease components and non-lease components for all underlying asset classes.

The adoption of this guidance had a material impact on the Company's Condensed Consolidated Balance Sheet beginning April 1, 2019 when the Company recognized (a) a lease liability of $771,098, which represents the present value of the remaining lease payments of $967,344, discounted using the Company's incremental borrowing rate of 5% and (b) the related right-of-use asset of $771,098 which represents the lease liability. Prior periods were not restated. Adoption of this standard had no change on financing leases previously subject to capital lease treatment under ASC Topic 840, Leases. See Note 9 for further discussion of leases. 

 

The Company determines if a contractual arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets, operating lease liability – current, and operating lease liability – noncurrent on the Company’s condensed consolidated balance sheets. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date of the lease based on the present value of lease payments over the lease term. The lease payments included in the present value are fixed lease payments. As most of the Company’s leases do not provide an implicit rate, the Company estimates its collateralized incremental borrowing rate, based on information available at the commencement date, in determining the present value of lease payments. The operating lease ROU assets include any payments made before the commencement date and exclude lease incentives. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

RECLASSIFICATION

 

Certain amounts in the prior periods presented have been reclassified to conform to the current period financial statement presentation.  These reclassifications have no effect on previously reported net income.

RECENT ACCOUNTING PRONOUNCEMENTS

 

In June 2016,

NEW ACCOUNTING STANDARDS

On December 18, 2019, the FASB issued ASU-2016-13 “Financial Instruments – Credit Losses”. This guidance affects organizations that hold financial assets and net investmentsASU 2019-12, “Simplifying the Accounting for Income Taxes”, which modifies ASU 740 to simplify the accounting for income taxes. The amendments in leases thatASU 2019-12 are not accounted for at fair value with changes in fair value reported in net income. The guidance requires organizations to measure all expected credit losses for financial instruments at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts. It is effective for fiscal years beginning after December 15, 2019. 2020. The Company adopted this ASU as of effective April 1, 2020 and it has no impact on the Company’s consolidated financial statements.2021.

 

Management does not believe that any other recently issued, but not yet effective accounting pronouncement, if adopted, would have a material effect on the accompanying consolidated financial statements.

 

 

NOTE3- INVENTORIES       

 

Inventories at September 30, 2020

Inventories at September 30, 2021 consisted of the following:

 

 

Current

  

Long Term

  

Total

  

Current

  

Long Term

  

Total

 

Raw materials

 $384,975  $121,013  $505,988  $241,564  $202,846  $444,410 

Finished goods

  69,342   11,067   80,409   54,724   8,788   63,512 

Totals

 $454,317  $132,080  $586,397  $296,288  $211,634  $507,922 

 

Inventories at March 31, 2020

Inventories at March 31, 2021 consisted of the following:

 

 

Current

  

Long Term

  

Total

  

Current

  

Long Term

  

Total

 

Raw materials

 $289,369  $121,013  $410,382  $139,361  $202,846  $342,207 

Finished goods

  83,266   11,067   94,333   87,873   8,788   96,661 

Totals

 $372,635  $132,080  $504,715  $227,234  $211,634  $438,868 

 

10

 

 

NOTE4- PROPERTY AND EQUIPMENT

 

Property and equipment as of September 30, 2020 2021 and March 31, 2020 2021 is as follows:

 

 

September 30,

 

March 31.

 
 

September 30, 2020

  

March 31,2020

  

2021

  

2021

 

Machinery and equipment

 $199,810  $199,810  $199,810  $199,810 

Leasehold improvements

  3,750   3,750   3,750   3,750 
  203,560   203,560  203,560  203,560 
         

Accumulated depreciation and amortization

  (164,353

)

  (145,602

)

  (196,820)  (181,289)
         

Property and equipment, net

 $39,207  $57,958  $6,740  $22,271 

 

 

 

NOTE5- INTANGIBLE ASSETS

 

Intangible assets are being amortized using the straight-line method over periods ranging from 10-15 years with a weighted average remaining life of approximately 6 years.

 

  

September 30, 2020

  

March 31, 2020

 
  

Cost

  

Amortization

Period

(Years)

  

Accumulated Amortization

  

Net

Carrying Amount

  

Cost

  

Amortization

Period

(Years)

  

Accumulated Amortization

  

Net

Carrying Amount

 

Patents & Trademarks

 $35,794  10-15  $(15,430) $20,364  $35,794  10-15  $(14,091) $21,703 
  

September 30, 2021

  

March 31, 2021

 
  

Cost

  

Weighted Average Amortization Period (Years)

  

Accumulated Amortization

  

Net Carrying Amount

  

Cost

  

Weighted Average Amortization Period (Years)

  

Accumulated Amortization

  

Net Carrying Amount

 

Patents & Trademarks

 $35,794  10-15  $(18,311) $17,483  $35,794  10-15  $(16,871) $18,923 

 

Estimated aggregate future amortization expense related to intangible assets is as follows:

 

For the fiscal years ended March 31,

    

2021

 $2,882 

For the fiscal years ended September 30,

 

2022

  2,882  $2,882 

2023

  2,882  2,882 

2024

  2,798  2,798 

2025

  2,158  2,158 

2026

 2,222 

Thereafter

  6,762   4,541 
 $20,364  $17,483 

 

 

 

NOTE6 – CONCENTRATIONS

 

During the three months ended September 30, 2021, 2 customers accounted for 51% of our net revenue. During the three months ended September 30, 2020, two2 customers accounted for 49% of our net revenue.  

During the six months ended September 30, 2021, 2 customers accounted for 48% of our net revenue. During the six months ended September 30, 2020, two2 customers accounted for 51% of our net revenue.  

 

During the three months ended As of September 30, 2019, one customer accounted for 47% of our net revenue. During the six months ended September 30, 2019, one customer accounted for 47% of our net revenue.

As of September 30, 2020, three2021, 3 customers represented 77%71% of our gross accounts receivable. As of March 31, 2020, three2021, 3 customers represented 83%accounted for 81% of our gross accounts receivable.

 

11

The Company’s customer base is comprised of foreign and domestic entities with diverse demographics. Net revenues from foreign customers for the three and six months ended September 30, 2021 were $75,541 or 9% and $157,494 or 10%, respectively.

 

The Company’s customer base is comprised of foreign and domestic entities with diverse demographics. Net revenues from foreign customers for the three and six months ended September 30, 2020 were $98,822 or 11% and $123,488 or 8%, respectively.

 

Net revenues from foreign customers for the three and six months ended September 30, 2019 were $116,910 or 12% and $242,282 or 14%, respectively.

 

NOTE7- DISAGGREGATEDREVENUESAND SEGMENT INFORMATION

 

The following tables show the Company's revenues disaggregated by reportable segment and by product and service type:

 

 

Three months Ended September 30,

  

Three months Ended September 30,

 
 

2020

  

2019

  

2021

  

2020

 

Net Revenue in the US

         

Chemical

 $311,745  $295,739  $295,285  $311,745 

Electronics

  396,910   281,210  341,084  396,910 

Engineering

  119,608   262,932   139,949   119,608 
  828,263   839,881   776,318   828,263 
         

Net Revenue outside the US

         

Chemical

  98,822   116,910  $75,541  $98,822 

Electronics

  -   -  0  0 

Engineering

  -   -   0   0 
  98,822   116,910   75,541   98,822 
         

Total Revenues

 $927,085  $956,791  $851,859  $927,085 

 

 

 

Six Months Ended September 30,

  

Six Months Ended September 30,

 
 

2020

  

2019

  

2021

  

2020

 

Net Revenue in the US

         

Chemical

 $473,602  $557,999  $528,589  $473,602 

Electronics

  684,972   435,977  563,658  684,972 

Engineering

  214,116   551,354   323,476   214,116 
  1,372,690   1,545,330   1,415,723   1,372,690 
         

Net Revenue outside the US

         

Chemical

  123,488   242,282  $157,494  $123,488 

Electronics

  -   -  0  0 

Engineering

  -   -   0   0 
  123,488   242,282   157,494   123,488 
         

Total Revenues

 $1,496,178  $1,787,612  $1,573,217  $1,496,178 

 

12

Information about segments is as follows:

 

 

Chemical

 

Electronics

 

Engineering

 

Total

 

Three months ended September 30, 2021

 

Revenue from external customers

 $370,826  $341,084  $139,949  $851,859 

Segment operating (loss)

 $(223,166) $(252,306) $(77,102) $(552,574)
 

Six months ended September 30, 2021

 

Revenue from external customers

 $686,083  $563,658  $323,476  $1,573,217 

Segment operating income (loss)

 $(234,273) $(345,779) $(15,519) $(595,571)
 

Chemical

  

Electronics

  

Engineering

  

Total

  

Three months ended September 30, 2020

                 

Revenue from external customers

 $410,567  $396,910  $119,608  $927,085  $410,567  $396,910  $119,608  $927,085 

Segment operating income (loss)

 $(11,158) $(61,299) $77,823  $5,366  $(11,158) $(61,299) $77,823  $5,366 
                 

Six months ended September 30, 2020

                 

Revenue from external customers

 $597,090  $684,972  $214,116  $1,496,178  $597,090  $684,972  $214,116  $1,496,178 

Segment operating income (loss)

 $(56,310) $(176,104) $53,910  $(178,504) $(56,310) $(176,104) $53,910  $(178,504)
                 

Three months ended September 30, 2019

                

Revenue from external customers

 $412,649  $281,210  $262,932  $956,791 

Segment operating income (loss)

 $(42,634) $(29,524) $28,410  $(43,748)
                 

Six months ended September 30, 2019

                

Revenue from external customers

 $800,281  $435,977  $551,354  $1,787,612 

Segment operating income (loss)

 $32,267  $(86,384) $79,654  $25,537 

Total assets at September 30, 2021

 $2,130,678  $1,783,823  $1,040,564  $4,955,065 
                 
                

Total assets at September 30, 2020

 $2,107,549  $2,423,683  $737,642  $5,268,874 
                

Total assets at March 31, 2020

 $2,021,235  $1,970,705  $1,061,149  $5,053,089 

Total assets at March 31, 2021

 $2,033,499  $2,294,203  $886,397  $5,214,099 

 

 

 

NOTE8 – ACCOUNTS RECEIVABLE - RELATED PARTY   

 

The Company has a $75,000 investment for approximately 23%23.2% of Qol Devices Inc. (Qol), which is carried at cost and reported as a component of other assets in the accompanying consolidated balance sheets.

 

The Company provided $330,090 in engineering services to Qol during the year March 31, 2018. AsQol owes the Company $330,090 as of March 31, 2021. The receivable is shown net of a $250,000 allowance for doubtful accounts on the consolidated balance sheets as of September 30, 2020, the Company reported a long term receivable as a component of other assets in the accompanying consolidated balance sheets.2021 and March 31, 2021.

 

 

 

NOTE9 – LEASES

 

We lease our office and manufacturing facility under a non-cancelable operating lease, which expires on June 30, 2028. The following is a maturity analysis of the annual undiscounted cash flows of the operating lease liabilities as of September 30, 2020:2021: 

 

For the Years Ending September30,

    

2021

 $101,875 

For the Period Ending September 30,

 

2022

  101,875  $101,875 

2023

  103,125  103,125 

2024

  106,875  106,875 

2025

  106,875  106,875 

2026

 106,875 

Thereafter

  293,915   187,031 
  814,540  712,656 

Less: Amount attributable to imputed interest

  (141,852

)

  (109,805

)

Net liability at September 30, 2020

 $672,688 

Net liability at September 30, 2021

 $602,851 
     

Weighted average remaining lease term (in years)

  8.0  7.0 

Weighted average discount rate

  5.00

%

 5.00

%

 

Rent and real estate tax expense for all facilities for the three and six months ended September 30, 2021 was approximately $35,000 and $69,000, respectively. Rent and real estate tax expense for all facilities for the three and six months ended September 30, 2020 and 2019 was approximately $34,000 and $68,000, respectively, and $32,000 and $67,000, respectively andrespectively. These are reported as a component of cost of sales and selling, general and administrative expenses in the accompanying statementconsolidated statements of operations. The Company paid in $50,928 in lease payments during the six months ending September 30, 2020.

 

13

 

During September 2016 the Company leased equipment with a cost of approximately $129,000, under provisions of various long-term financing leases whereby the minimum lease payments have been capitalized. Accumulated depreciation at September 30, 2020 is approximately $101,000. The leases expire over various years through 2021. Depreciation of the leased assets is included in depreciation and amortization expense. The lease obligations are secured by the leased assets.

 

NOTE10 – PAYROLL PROTECTION PROGRAM (PPP)Loan

 

The World Health Organization characterized the COVID-19 virus as a global pandemic on March 11, 2020.  The duration and economic impact of this pandemic are uncertain.  The economic impact depends on future developments and the financial condition of our customers that we may not be able to foresee. Any of these factors, and other factors beyond our control, can adversely impact our results for the full fiscal year and such impact may be material.  At this time, management is unable to quantify its potential effects on the operations and financial performance of the Company.

On In May 6, 2020, the Company received loan proceeds in the amount of approximately $381,000 underobtained funding through the Small Business Administration ("SBA"(“SBA”) Paycheck Protection Program (“PPP”). of $381,000.  In February 2021, second PPP loan was obtained in the amount of $332,542, for a total of $713,542.  The PPP,loans will be fully forgiven if the funds are used for payroll costs, interest on mortgages, rent, and utilities, with at least 60% being used for payroll.  The Company did use the funds for these expenses during the year ended March 31, 2021. The Company applied for loan forgiveness of the first PPP funds on August 3, 2021. On September 7, 2021, the Company received approval from the SBA for $361,275 of PPP loan forgiveness. This amount was recorded as Forgiveness will be reduced if full-time headcount declines, or if salaries and wages decrease. Principal and interest payments on anyof Paycheck Protection loan in the accompanying condensed Consolidated Statements of Operations during the six months ended September 30, 2021.

The unforgiven portion of the firstPPP will be deferredloan is $19,725, which was converted to a term loan payable in equal installments of principal plus interest at 1% with a maturity date of May 15, 2025. The first payment of $737.05 is due on October 15, 2021. No collateral or personal guarantees were required for the date the SBA remits the borrower’s loan forgiveness amount to the lender or, if the borrower does not apply for loan forgiveness, 10 months after the end of the borrower’s loan forgiveness covered period.loans. This loan hasPPP loans bear an interest rate of 1% and a maturity of 2two years, which can be extended to up to 5five years if the Company and the lender agree. No collateral or personal guarantees were required forThe second PPP loan has not been forgiven as of September 30, 2021. We have elected to treat the loan.

The Company intends to use the entire PPP proceeds for designated qualifying expenses and to apply for forgiveness of the PPP in accordance with the terms of the PPP. No assurance can be given thatloan under FASB ASC 470, Debt. When the Company will obtainis successful in obtaining forgiveness, of the PPP in whole or in part. With respect to any portion of the PPP that is not forgiven, the PPPloan will be subject to customary provisions fortreated as a loangain upon extinguishment of this type, including customary events of default relating to, among other things, payment defaults, breaches of the provisions of the PPP note and cross defaultsdebt under ASC 405, Liabilities.

 

 

 

NOTE11 – LINE OF CREDIT

 

On June 15, 2018, the Company obtained an unsecured revolving line of credit, with a limit of $400,000. The line expires May 15, 2021, 2022renewing automatically every year.  The Company is required to make monthly interest payments, at a rate of 3.870%3.87% as of September 30, 2020. 2021. Any unpaid principal will be due upon maturity.  At September 30, 2020 2021 and March 31, 2020, 2021, the outstanding balance was $55,000$253,742 and $30,000,$226,413, respectively.

 

 

 

NOTE12- INCOME TAXES

 

At  September 30, 2020, 2021, the Company had federal net operating loss carry-forwards ("NOLs") of approximately $2,629,000.$3,211,000. These NOLs  may be used to offset future taxable income and thereby reduce or eliminate our federal income taxes otherwise payable. A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized. Ultimate utilization of such NOLs and research and development credits is dependent upon the Company's ability to generate taxable income in future periods and  may be significantly curtailed if a significant change inownership occurs.

 

During the six months ended September 2020, 30, 2021, the Company generated approximately $160,000$401,000 of the net operating losses, and expects to utilize the NOL’s before expiration.

 

The effective tax rates were approximately 1%71% and 30%.93% for the six months ended September 30, 2020 2021 and 2019,2020, respectively. 

 

 

 

NOTE13 – STOCK BASED COMPENSATION

 

On January 13, 2020, ADM granted 300,000 stock options to one employee at an exercise price of $0.20 per option with a term of two years subject to vesting in four equal amounts of 75,000 shares every six months. The options were valued at $35,206 using the Black Scholes option pricing model with the following assumptions: risk free interest rate of 1.58%, volatility of 132%, estimated useful life of 3 years and dividend rate of 0%.

 

14

The following table summarizes information on all common share purchase options issued by us as of September 30, 2020 2021 and 2019.2020.

  

2021

  

2020

 
  

# of Shares

  

Weighted

  

# of Shares

  

Weighted

 
      

Average

      

Average

 
      

Exercise

      

Exercise

 
      

Price

      

Price

 
                 

Outstanding, beginning of year

  300,000  $0.20   300,000  $0.20 
                 

Issued

  0   0   0   0 
                 

Exercised

  0   0   0   0 
                 

Expired

  0   0   0   0 
                 

Cancelled

  (300,000

)

  0.20   0   0 
                 

Outstanding, end of period

  0  $0   300,000  $0.20 
                 

Exercisable, end of period

  0  $0   0  $0 

 

 

  

2020

  

2019

 
  

# of Shares

  

Weighted

  

# of Shares

  

Weighted

 
      

Average

      

Average

 
      

Exercise

      

Exercise

 
      

Price

      

Price

 
                 

Outstanding, beginning of year

  300,000  $.20   -  $- 
                 

Issued

  -   -   -   - 
                 

Exercised

  -   -   -   - 
                 

Expired

  -   -   -   - 
                 

Outstanding, end of period

  300,000  $0.20   -   - 
                 

Exercisable, end of period

  75,000  $0.20   -   - 

The following table summarizes the information about nonvested options for the six months ended September 30, 2020:

  

Options

  

Weighted Average Exercise Price

 

Nonvested - April 1, 2020

  300,000     
         

Granted

  -  $- 

Vested

  (75,000)  0.20 

Cancelled

  -   - 

Forfeited

  -   - 
         

Nonvested - September 30, 2020

  225,000     

Stock based compensation related to the vested option was $8,802 and $0 for the six months ended September 30, 2020 and 2019, respectively.NOTE14 – WARRANT LIABILITY

 

On July 2, 2021, ADM entered into a consulting agreement. The agreement granted a consultant a warrant to purchase up to 3,500,000 shares of the Company's par value common stock at an exercise price of $0.17 per share for the firsttwelve months of the agreement and $0.20 per share for the secondtwelve months of the agreement.

The warrants were classified as a liability in the total amount of $287,844 at September 30, 2021 using the Black Scholes option pricing model with the following assumptions: risk free interest rate of 1.58%, volatility of 143%, estimated useful life of 2 years and dividend rate of 0%.

In addition, the warrants must be valued every reporting period and adjusted to market with the increase or decrease being adjusted through earnings. As of September 30, 2020, there2021, the fair value of the warrant liability was $26,404 of unrecognized compensation costs, which is expected to be recognized as follows:$287,844.

 

For the years ending September 30,

 

Amount

 

2021

 $11,735 

2022

  11,735 

2023

  2,934 
  $26,404 

 

 

NOTE 1415 – DUE TO STOCKHOLDER

 

The Company’s President has been deferring his salary and bonuses periodically to assist the Company’s cash flow. There are no0 repayment terms or interest accruing on this liability. 

 

 

 

NOTE 1516 – LEGAL PROCEEDINGS

In November 2019, the Company filed a civil suit in the Superior Court of New Jersey against an accounting firm seeking a declaratory judgement from the court that no sum is due to the accounting firm, plus damages, attorney's fees and costs with respect to the foregoing. This matter was settled by mutual agreement for the Company to pay $7,500 to the defendant. All claims were dismissed by both parties on June 2, 2020.

 

We are involved, from time to time, in litigation and proceedings arising out of the ordinary course of business. Other than the foregoing, thereThere are no pending material legal proceedings or environmental investigations to which we are a party or to which our property is subject. 

 

 

 

NOTE 1617 – SUBSEQUENT EVENTS

The World Health Organization characterized the COVID-19 virus as a global pandemic on March 11, 2020.  The duration and economic impact of this pandemic are uncertain.  The economic impact depends on future developments and the financial condition of our customers that we may not be able to foresee. Any of these factors, and other factors beyond our control, can adversely impact our results for the full fiscal year and such impact may be material.  At this time, management is unable to quantify its potential effects on the operations and financial performance of the Company.

 

We evaluated all subsequent events from the date of the condensed consolidated balance sheetsheets through the issuance date and determined that there are no events or transactions occurring during the subsequent event reporting period which require recognition or disclosure in the condensed consolidated financial statements. 

 

15

 

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion of our operations and financial condition should be read in conjunction with the condensed consolidated financial statements and notes thereto included elsewhere in this Quarterly Report on Form 10-Q. 

 

FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the "safe harbor" provisions under section 21E of the Securities and Exchange Act of 1934 and the Private Securities Litigation Act of 1995. We use forward-looking statements in our description of our plans and objectives for future operations and assumptions underlying these plans and objectives. Forward-looking terminology includes the words "may", "expects", "believes", "anticipates", "intends", "forecasts", "projects", or similar terms, variations of such terms or the negative of such terms. These forward-looking statements are based on management's current expectations and are subject to factors and uncertainties which could cause actual results to differ materially from those described in such forward-looking statements. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained in this Form 10-Q to reflect any change in our expectations or any changes in events, conditions or circumstances on which any forward-looking statement is based. Factors which could cause such results to differ materially from those described in the forward-looking statements include those set forth under "Item. 1 Description of Business – Risk Factors" and elsewhere in or incorporated by reference into our Annual Report on Form 10-K for the year ended March 31, 2019.2021.

 

CRITICAL ACCOUNTING POLICIES

 

REVENUE RECOGNITION

 

ELECTRONICS: 

 

We recognize revenue from the sale of our electronic products when they are shipped to the purchaser. We offer a limited 90-day warranty on our electronics products and contract manufacturing and a limited 5-year warranty on our electronic controllers for spas and hot tubs. Historically, the amount of warranty revenue included in sales of our electronic products have been de minimus. We have no other post shipment obligations. 

 

Amounts received from customers in advance of our satisfaction of applicable performance obligations are recorded as customer deposits. Such amounts are recognized as revenues when the related performance obligations are satisfied. Customer deposits of approximately $190,000$115,000 as of March 31, 20202021 were recognized as revenues during the six months ended September 30, 2020.2021.

 

CHEMICAL PRODUCTS:

 

Revenues are recognized when products are shipped to end users. Shipments to distributors are recognized as revenue when no right of return exists.

 

ENGINEERING SERVICES: 

 

We provide certain engineering services, including research, development, quality control, and quality assurance services along with regulatory compliance services. We recognize revenue from engineering services on a monthly basis over time as the applicable performance obligations are satisfied.  

 

All revenue is recognized net of discounts.

 

USE OF ESTIMATES

 

These unaudited condensed consolidated financial statements have been prepared in accordance with US GAAP and, accordingly, requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. Significant estimates made by management include expected economic life and value of our of our deferred tax assets and related valuation allowance, write down of inventory, impairment of long-lived assets, allowance for doubtful accounts, and warranty reserves. Actual results could differ from those estimates. 

 

LEASES

 

In February 2016, the Financial Accounting Standards Board (“FASB”)FASB issued authoritative guidance which changes financial reporting as it relates to leasing transactions. Under the new guidance, lessees are required to recognize a lease liability, measured on a discounted basis; and a right-of-use asset, for the lease term. The Company adopted this guidance as of April 1, 2019, using the modified retrospective approach which allowed it to initially apply the guidance as of the adoption date. The Company elected the package of practical expedients available under the new standard, which allowed the Company to forgo a reassessment of (1) whether any expired or existing contracts are or contain leases, (2) the lease classification for any expired or existing leases, and (3) the initial direct costs for any existing leases.

 

16

 

The Company made a policy election to recognize short-term lease payments as an expense on a straight-line basis over the lease term. The Company defines a short-term lease as a lease that, at the commencement date, has a lease term of twelve months or less and does not contain an option to purchase the underlying asset that the lease is reasonably certain to exercise. Related variable lease payments are recognized in the period in which the obligation is incurred. 

 

The Company's lease agreement contains related non-lease components (e.g. taxes, etc.). The Company separates lease components and non-lease components for all underlying asset classes.

 

The adoption of this guidance had a material impact on the Company's Condensed Consolidated Balance Sheet beginning April 1, 2019, when the Company recognized (a) a lease liability of $771,098,$821,020, which represents the present value of the remaining lease payments of $967,344, discounted using the Company's incremental borrowing rate of 5% and (b) the related right-of-use asset of $771,098 which represents the lease liability.$821,020. Prior periods were not restated. Adoption of this standard had no change on financing leases previously subject to capital lease treatment under ASC Topic 840, Leases. See Note 9 for further discussion of leases. 

 

The Company determines if a contractual arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets, operating lease liability – current, and operating lease liability – noncurrent on the Company’s condensed consolidated balance sheets. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the commencement date of the lease based on the present value of lease payments over the lease term. The lease payments included in the present value are fixed lease payments. As most of the Company’s leases do not provide an implicit rate, the Company estimates its collateralized incremental borrowing rate, based on information available at the commencement date, in determining the present value of lease payments. The operating lease ROU assets include any payments made before the commencement date and exclude lease incentives. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

 

BUSINESS OVERVIEW

 

The Company is a technology-based developer and manufacturer of diversified lines of products and derives revenue from the production and sale of electronics for medical devices and other applications; environmentally safe chemical products for industrial, medical and cosmetic uses; and, research, development, regulatory and engineering services. The Company has increased internal research and development by utilizing their engineering resources to advance their own proprietary medical device technologies.

 

The Company is a corporation that was organized under the laws of the State of Delaware on November 24, 1969. Our operations are conducted through ADM Tronics Unlimited, Inc. ("ADM") and its subsidiary Sonotron Medical Systems, Inc. ("Sonotron").Sonotron.  

 

RESULTS OF OPERATIONS FOR THETHREE AND SIX MONTHS MONTHS ENDEDSEPTEMBER 30, 2020 2021AS COMPARED TOSEPTEMBER 30, 2019  2020.

 

Revenues for the three and six months ended September 30, 20202021 decreased by $29,706$75,226 and $291,434,increased $77,039, respectively. The three-month decrease is a result of decreased sales of $2,082$39,741 in the Chemical segment and $143,324$55,826 in the EngineeringElectronic segment offset by an increase of $115,700$20,341 in the ElectronicsEngineering segment. The six-month decreaseincrease is a result of decreased sales of $203,191$121,314 in the ChemicalElectronic segment and $337,238offset by increases of $109,360 in the Engineering segment offset by an increase of $248,995and $88,993 in the ElectronicsChemicals segment.

 

Gross profit for the three months ended September 30, 2020 decreased by $63,804. Gross profit for theand six months ended September 30, 20202021 decreased by $331,026.$2,793 and increase by $114,889, respectively. The decreaseincrease in gross profit resulted primarily from decreasedincreased sales in Engineering and Chemical and Engineering related to the COVID-19 pandemic.sales coupled with a minimal increase in cost of sales.

 

We are highly dependent upon certain customers. During the three months ended September 30, 2021, two customers accounted for 51% of our net revenue. Net revenues from foreign customers for the three months ended September 30, 2021 was $75,541 or 9%.

During the six months ended September 30, 2021, two customers accounted for 48% of our net revenue. Net revenues from foreign customers for the six months ended September 30, 2021 was $157,494 or 10%.

During the three and six months ended September 30, 2020, two customers accounted for 49% and 51% of our net revenue.revenue, respectively. Net revenues from foreign customers for the three and six months ended September 30, 2020 was $98,822 or 11% and $123,488 or 8%, respectively.

During the three months ended September 30, 2019, one customer accounted for 47% of our net revenue. During the six months ended September 30, 2019, one customer accounted for 47% of our net revenue. Net revenues from foreign customers for the three and six months ended September 30, 2019 were $116,910 or 12% and $242,282 or 14%, respectively.

 

The complete loss of or significant reduction in business from, or a material adverse change in the financial condition of any of our customers could cause a material and adverse change in our revenues and operating results.

 

17

Income

Loss from operations for the three months ended September 30, 2021 was ($552,574) compared to income from operations for the three months ended September 30, 2020 increased by $49,114. Incomeof $5,366 mainly due to consulting expense of $287,844 as a result of warrants issued during the quarter and bad debt expense of $200,000.

Loss from operations for the six months ended September 30, 2021 was ($595,571) compared to a loss from operations for the six months ended September 30, 2020 decreased by $204,041. The increase in operating income for the three-month period is from a decrease in income from the Chemical segment of $50,515 offset increases in income of $50,217 from the Electronic segments and an increase of $49,412 from Engineering.($178,504).

 

The decrease in operatingOther income for the six-month period is from a decrease in income from the Chemical segment of $170,568, a decrease in income of $7,728 from the Electronic segmentsincreased $355,555 and a decrease of $25,745 from Engineering.

17

Income from operations$342,746 for the three months ended September 30, 2019 decreased by $130,203. The decrease in operating income for the three-month period is from an increase of the following expenses: approximately $18,000 in accounting fees, $17,000 in administrative salary, $30,000 in health insurance, and $41,000 in research and development.

Income from operations for the six months ended September 30, 2019 decreased by $78,014. The decrease in operating income for the six-month period is primarily from an increase of the following expenses: approximately $18,000 in accounting fees, $22,000 in health insurance, and $78,000 in research and development offset by decreases in consulting fees of $45,000.

Other income decreased $1,794 for the three months ended September 30, 2020 and increased $6,356 for the six months ended September 30, 2020.2021, respectively. The increase is primarily due EIDL grantattributable to the forgiveness of $10,000 offset by decreasethe PPP Loan in funds invested in a money market account.the amount of $361,275.

 

The foregoing resulted in a net incomeloss before provision for income taxes for the three months ended September 30, 20202021 of $8,911 and$193,474. Earnings per share were $(0.00) for the three months ended September 30, 2021. A net loss of $161,325before provision for income taxes for the six months ended September 30, 2020.2021 of $237,646. Earnings per share were $0.00 and $(0.00) for the three and six months ended September 30, 2020.2021.

 

LIQUIDITY AND CAPITAL RESOURCES   

 

At September 30, 2020,2021, we had cash and cash equivalents of $1,459,211$1,264,488 as compared to $1,438,714$1,546,950 at March 31, 2020.2021. The $20,497 increase$282,462 decrease was primarily the result of cash used in operations during the six-month period in the amount of $369,410,$299,440, offset with cash provided in financing activities of $389,907.$16,978. Our cash will continue to be used for increased marketing costs, and increased production labor costs all in an attempt to increase our revenue, as well as increased expenditures for our internal R&D.  We expect to have enough cash to fund operations for the next twelve months.    

 

Future Sources of Liquidity:

 

We expect that growth with profitable customers and continued focus on new customers will enable us to continue to generate cash flows from operating activities during fiscal 2020.2022. 

 

Based on current expectations, we believe that our existing cash and cash equivalents of $1,459,211$1,264,488 as of September 30, 2020,2021, and other potential sources of cash will be sufficient to meet our cash requirements. Our ability to meet these requirements will depend on our ability to generate cash in the future, which is subject to general economic, financial, competitive, legislative, regulatory and other factors that are beyond our control.

 

OPERATING ACTIVITIES

 

Net cash used by operating activities was $369,410$299,440 for the six months ended September 30, 2020,2021, as compared to net cash providedused by operating activities of $257,495$340,670 for the six months ended September 30, 2019.2020. The cash used during the six months ended September 30, 20202021 was primarily due to an increase in net lossoperating assets of $159,825 less depreciation and amortization of $20,090 coupled with$153,430, a decrease in net operating liabilities of $40,408 and$150,342, PPP loan forgiveness of $361,275, an increase in deferred taxes of $150,000, and net operating assetsloss of $279,885.$67,828, partially offset by write-off of inventories of $21,979, write-off of $200,000 of bad debt, depreciation and amortization of $58,023, issuance of warranty liability of $287,844, and non-cash interest expense of $15,589.

 

INVESTING ACTIVITIES

 

No cash was provided for or used in investing activities for the six months ended September 30, 2020.2021.

 

FINANCING ACTIVITIES

 

For the six months ended September 30, 2020,2021, net cash provided by financing activities was $389,907$16,978 due to net advances from the line of credit of $25,000, proceeds from the PPP loan$27,329 and a decrease in due to stockholder of $381,000 offset by repayments on finance lease obligations of $16,093. $10,351.

 

OFF BALANCE SHEET ARRANGEMENTS

 

We have no off-balance sheet arrangements that have had or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

 

18

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Concentration of Credit Risk

 

Financial instruments that potentially subject us to significant concentrations of credit risk consist primarily of cash and cash equivalents and accounts receivable.

 

Cash and cash equivalents – For financial statement purposes, the Company considers as cash equivalents all highly liquid investments with an original maturity of three months or less at inception. The Company deposits cash and cash equivalents with high credit quality financial institutions and believes that any amounts in excess of insurance limitations to be at minimal risk. Cash and cash equivalents held at these accounts are currently insured by the Federal Deposit Insurance Corporation (“FDIC”) up to a maximum of $250,000. At September 30, 2020,2021, approximately $1,305,000$1,051,000 exceeded the FDIC limit.

 

Our sales are materially dependent on a small group of customers, as noted in Note 46 of our condensed consolidated financial statements. We monitor our credit risk associated with our receivables on a routine basis. We also maintain credit controls for evaluating and granting customer credit. 

 

ITEM 4. CONTROLS AND PROCEDURES

 

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

 

The Company's management, including the Company's principal executive officer and principal financial officer, have evaluated the effectiveness of the Company's "disclosure controls and procedures," as such term is defined in Ru1e 13a-15(e) promulgated under the Securities Exchange Act of 1934, as amended, (the "Exchange Act"). Based upon their evaluation, the principal executive officer and principal financial officer concluded that, as of the end of the period covered by this report, the Company's disclosure controls and procedures were not effective for the purpose of ensuring that the information required to be disclosed in the reports that the Company files or submits under the Exchange Act with the Securities and Exchange Commission (the "SEC") (1) is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and (2) is accumulated and communicated to the Company's management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. During the quarterly and year to date period ended September 30, 2020,2021, there were no changes in the Company's internal control over financial reporting which materially affected, or are reasonably likely to materially affect, the Company's internal controls over financial reporting. 

 

The determination that our disclosure controls and procedures were not effective as of September 30, 2020,2021, is a result of:

 

a. Deficiencies in Internal Control Structure Environment. During the current year, the Company’s focus was on expanding their customer base to initiate revenue production.  

 

b. Inadequate staffing and supervision within the accounting operations of our company. The relatively small number of employees who are responsible for accounting functions prevents the Company from segregating duties within its internal control system. The inadequate segregation of duties is a weakness because it could lead to the untimely identification and resolution of accounting and disclosure matters or could lead to a failure to perform timely and effective reviews.  The Company’s plan is to expand its accounting operations as the business of the Company expands. 

 

The Company believes that the financial statements present fairly, in all material respects, the Company’s condensed consolidated balance sheets as of September 30, 2020,2021, and March 31, 20202021 and the related condensed consolidated statements of income,operations, and cash flows for the three and six months ended September 30, 20202021 and 2019,2020, in conformity with generally accepted accounting principles, notwithstanding the material weaknesses we identified. 

 

CHANGES IN INTERNAL CONTROLS OVER FINANCIAL REPORTING

 

There were no changes in our internal control over financial reporting that occurred during our last fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

In November 2019, the Company filed a civil suit in the Superior Court of New Jersey against an accounting firm seeking a declaratory judgement from the court that no sum is due to the accounting firm, plus damages, attorney's fees and costs with respect to the foregoing. This matter was settled by mutual agreement for the Company to pay $7,500 to the defendant. All claims were dismissed by both parties on June 2, 2020. Other than the foregoing, there are no pending material legal proceedings or environmental investigations to which we are a party or to which our property is subject.None

 

ITEM 1A. RISK FACTORS

 

There have been no material changes to the risk factors contained in our Annual Report on Form 10-K for the year ended March 31, 2020.2021. 

 

19

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None 

 

ITEM 4.MINE SAFETY DISCLOSURES

 

None

 

ITEM5. OTHER INFORMATION

 

None 

 

20

ITEM6. EXHIBITS.

 

(a) Exhibit No.

 

31.1

31.1 Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

32.1

32.1 Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

101.INS**

Inline XBRL Instance

101.SCH**

Inline XBRL Taxonomy Extension Schema

101.CAL**

Inline XBRL Taxonomy Extension Calculation

101.DEF**

Inline XBRL Taxonomy Extension Definition

101.LAB**

Inline XBRL Taxonomy Extension Labels

101.PRE**

Inline XBRL Taxonomy Extension Presentation

104

Cover Page Interactive Data File (embedded within the Inline XBRL and contained in Exhibit 101)

 

** XBRL information is furnished and not filed or a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

ADM TRONICS UNLIMITED, INC.

(Registrant)

By:

/s/ Andre' DiMino

Andre' DiMino, Chief Executive

Officer and Chief Financial

Officer

 

Dated:

Northvale, New Jersey

November 16, 2020

22, 2021

 

2021